Dermal distribution of hyaluronan in psoriatic arthritis; coexistence of CD44, MMP3 and MMP9.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Acta Dermato-Venereologica

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2340/00015555-1286PMID 22278305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB.

  2007cited by this paper
• Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

  2006cited by this paper
• Threat matrix

  2005cited by this paper
• Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process

  2005cited by this paper
• Hyaluronan-oligosaccharide-induced transcription of metalloproteases

  2004cited by this paper
• Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces

  2004cited by this paper
• Hyaluronan participates in the epidermal response to disruption of the permeability barrier in vivo.

  2004cited by this paper
• The stromal reaction in basal cell carcinomas. A prerequisite for tumour progression and treatment strategy.

  2004cited by this paper
• Resolution of Lung Inflammation by CD44

  2002cited by this paper
• EFFECT OF HYALURONAN ON MMP EXPRESSION AND ACTIVATION

  2001cited by this paper
• Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation.

  2001cited by this paper
• Psoriatic Arthritis: Interrelationships between Skin and Joint Manifestations Related to Onset, Course and Distribution

  2000cited by this paper
• Serum Levels of Hyaluronic Acid in Patients with Psoriatic Arthritis

  2000cited by this paper
• Production and elimination of hyaluronan in rheumatoid arthritis patients: estimation with a loading test.

  1999cited by this paper
• Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties*

  1999cited by this paper
• Hyaluronan: its nature, distribution, functions and turnover

  1997cited by this paper
• Hyaluronan in skin

  1997cited by this paper
• Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients.

  1996cited by this paper
• Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age.

  1992cited by this paper
• Seven different assays of hyaluronan compared for clinical utility.

  1992cited by this paper
• Histochemical localization of hyaluronan in psoriasis, allergic contact dermatitis and normal skin.

  1991cited by this paper
• An improved technique for hyaluronan histochemistry using microwave irradiation

  1990cited by this paper
• Assay of serum hyaluronic acid in clinical application.

  1989cited by this paper
• Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe.

  1988cited by this paper
• Hyaluronan in the rat with special reference to the skin.

  1988cited by this paper
• High levels of hyaluronate in suction blister fluid from active psoriatic lesions

  1987cited by this paper
• Circulating hyaluronate in psoriasis

  1985cited by this paper
• Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding properties from cartilage.

  1979cited by this paper
• Histochemistry of the dermal ground substance of initial psoriatic lesions

  1978cited by this paper

• CD44 signaling in skin wound healing and regeneration

  2025cites this paper
• Exploring Roflumilast Transferosomes in Pluronic -Hyaluronic Acid Hydrogel Through Comprehensive In-Vitro and In-Vivo Evaluation

  2025cites this paper
• MMP3 at the Crossroads: Linking Molecular Pathways to Disease Diagnosis and Therapy.

  2025cites this paper
• Hyaluronic acid application strategies for plant bioactive component delivery: A review.

  2024cites this paper
• Advances in hydrogels based cutaneous drug delivery system for management of psoriasis

  2024cites this paper
• Hyaluronic acid/silk fibroin nanoparticles loaded with methotrexate for topical treatment of psoriasis

  2024cites this paper
• Hyaluronic acid modified liposomes with enhanced transdermal delivery of methotrexate for psoriasis treatment.

  2024cites this paper
• CD44 targeted indirubin nanocrystal-loaded hyaluronic acid hydrogel for the treatment of psoriasis.

  2023cites this paper
• Matrix Metalloproteinases: biomarker of disease activity and prognosis in Spondyloarthritis. A narrative review.

  2022cites this paper
• Chitosan/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: A combined chemo-photodynamic therapy for psoriasis.

  2022cites this paper
• Novel approaches for the application of Herbs for Skin Care.

  2022cites this paper
• strategies skin treatment

  2022cites this paper
• Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment

  2022cites this paper
• Development and evaluation of nanocrystals loaded hydrogel for topical application

  2022cites this paper
• Hyaluronic acid-coated proglycosomes for topical delivery of tofacitinib in rheumatoid arthritis condition: Formulation design, in vitro, ex vivo characterization, and in vivo efficacy studies.

  2022cites this paper
• Nanoscale Topical Pharmacotherapy in Management of Psoriasis: Contemporary Research and Scope

  2022cites this paper
• Extracellular matrix alterations in the skin of patients affected by psoriasis

  2021cites this paper
• Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases

  2021influential citation
• Recent advances and prospects of hyaluronan as a multifunctional therapeutic system.

  2021cites this paper
• Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis

  2021cites this paper
• Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review

  2020cites this paper
• Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome

  2019cites this paper
• Hyaluronan Fragmentation During Inflammatory Pathologies: A Signal That Empowers Tissue Damage.

  2019cites this paper
• CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin

  2019cites this paper
• Hyaluronic acid, an efficient biomacromolecule for treatment of inflammatory skin and joint diseases: A review of recent developments and critical appraisal of preclinical and clinical investigations.

  2018cites this paper
• Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions

  2018cites this paper
• Application of vacuum sealing drainage to the treatment of seawater‐immersed blast‐injury wounds

  2016cites this paper
• Hyaluronic acid in psoriasis

  2015cites this paper
• High levels of serum hyaluronic acid in adults with dermatomyositis.

  2015cites this paper